Researchers at The University of Texas at Arlington have found a potential new pathway to regulate immune response and potentially control inflammatory diseases of the central nervous system such as meningitis and sepsis.
“We need to know what turns on inflammatory response to bacterial infection to be able to modulate the process,” said Subhrangsu Mandal, the UTA associate professor of chemistry who led the research.
“If we can do so, we can control inflammatory diseases of the central nervous system that have been hard to treat up to now, such as sepsis and meningitis, as well as cancer and muscular dystrophy, which can also be seen a kind of inflammation,” he added.
Mandal and his team’s research findings were published in Scientific Reports.
The researchers have found that the long non-coding RNA molecule HOTAIR present in white blood cells has the capacity to signal these cells to activate immune response in the presence of bacteria. RNA, or ribonucleic acid, is present in all living cells. Its primary role is to carry instructions from DNA.
“Knowing that HOTAIR has a role in the signaling pathway also means that we can use it as a biomarker for bacterial infection,” he added. “Simple blood tests could indicate infection much more quickly, enabling better treatment for patients of rapidly-moving diseases such as septic shock and meningitis, which have been hard to treat up to now.”
The researchers used the resources of UTA’s North Texas Genome Center to demonstrate that noncoding RNA expression – including HOTAIR – is induced in white blood cells treated with lipopolysaccharide, which are molecules found on the outer membrane of bacterial cells. The research showed that HOTAIR gene was expressed alongside cytokines, which are excreted by cells as part of immune response, and inflammatory response genes such as iNOS. As a result, it is possible to conclude that HOTAIR is a key regulator for pathogen-induced cytokine expression, immune response and inflammation.
“Long non-coding RNAs like HOTAIR are emerging as key regulators of cell signaling processes and many are expressed in immune cells and play a critical role in immune response,” Mandal said. “Previous research carried out with Marco Brotto in UTA’s College of Nursing and Health Innovation had already established a link between low flow of oxygen to tissues and HOTAIR, which has been linked to cancer.”
“Having a resource like the North Texas Genome Center really means that we can multiply our work looking at non-coding RNAs in general, a burgeoning field in biochemistry,” he added.
Fred MacDonnell, UTA chair of chemistry and biochemistry, congratulated Mandal on this new research.
“Basic science related to the pathways for immune response is critical as there have been very few successes up to now developing treatments for extreme inflammations like sepsis and meningitis, “ MacDonnell said.
The Latest on: Immune response
[google_news title=”” keyword=”immune response” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immune response
- Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccineon May 9, 2024 at 9:18 am
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an ...
- RNA-LPAs Induce Immune Responses in Glioblastoma Patientson May 9, 2024 at 7:45 am
RNA lipid particle aggregates (RNA-LPAs) induced immune responses against glioblastoma in a first-in-human trial, according to a report published in Cell.1 The RNA-LPAs were designed to “enhance the ...
- Supercharging immune cells to battle blood cancer: Advances in cancer immunotherapyon May 9, 2024 at 6:51 am
Cancer has a profound impact on human life, and immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment. However, ICT faces challenges such as low overall response rates and ...
- Researchers at UC Santa Barbara Find That a New Mother’s Immune Status Varies with Her Feeding Strategyon May 9, 2024 at 5:00 am
According to a paper published in the journal Scientific Reports, certain inflammatory proteins — substances that are secreted as part of an immune response — peak at different times of day, ...
- New mRNA vaccine for deadly brain cancer triggers a strong immune responseon May 9, 2024 at 4:00 am
For the first time, scientists have tested a messenger RNA (mRNA) vaccine in a patient with a deadly form of brain cancer — and it triggered a strong immune response. The vaccine, which was described ...
- A new mother's immune status varies with her feeding strategyon May 7, 2024 at 3:33 pm
In one of the first studies of its kind, UC Santa Barbara researchers have found that the immune status of postpartum mothers shifts with how she feeds her baby. Certain inflammatory proteins -- ...
- New mRNA cancer vaccine helps immune system fight deadly brain tumorson May 7, 2024 at 8:23 am
Researchers from the University of Florida have developed a new mRNA cancer vaccine to retrain the body's immune system to attack and potentially treat glioblastoma, a deadly form of brain cancer.
- Neural circuits revealed as key regulators in body's immune response, study findson May 6, 2024 at 10:18 pm
A recent study in Nature reveals how specific neural circuits within the body-brain axis regulate immune responses, highlighting potential new therapeutic approaches for immune disorders.
- Hacking the immune system could slow ageing — here’s howon May 6, 2024 at 4:59 pm
Yet all she had done was to briefly treat them — many weeks earlier — with a drug that corrected the organization of proteins inside a type of stem cell. When technicians who were replicating her ...
via Bing News